Sanofi Inaugurates Lantus® SoloSTAR® Pen Assembly Plant in its Beijing Facility - The Group Pledges Continuous Commitment to Diabetes Management in China
Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the inauguration of a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus® SoloSTAR® at its Beijing plant located at the Beijing Economic-Technological Development Area (BDA).